does semaglutide help arthritis linked to reduced knee pain in people with obesity, study finds Anti-obesity drug has life-changing benefits

[DOI] [PubMed] [Google Scholar] 14.Weghuber D., Barrett T., Barrientos-Perez M., Gies I., Hesse D., Jeppesen O.K., Kelly A.S., Mastrandrea L.D., Sorrig R., Arslanian S., et al

Patients with more advanced kidney disease should consult a nephrologist and work with PlexusDx medical staff to determine safe dosing and monitoring

Patient Options and Next Steps Patients who have relied on compounded versions of these drugs are now facing limited alternatives

Date, time, peptide, and dose form the basic record

By February 2026, eight GLP-1 RAs have received FDA approval, primarily for glycemic control in T2D and chronic weight management in obesity, with expanding cardiovascular (CV) benefits demonstrated in large-scale trials